Moss D J, Lutzky V P
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Curr Top Microbiol Immunol. 2015;390(Pt 1):23-42. doi: 10.1007/978-3-319-22822-8_3.
Early research on Epstein-Barr virus (EBV) developed from serological observations that were made soon after the discovery of the virus. Indeed, the definition of the humoral response to a variety of EBV proteins dominated the early literature and was instrumental in providing the key evidence for the association of the virus with infectious mononucleosis (IM), Burkitt's lymphoma (BL), and nasopharyngeal carcinoma (NPC). Each of these disease associations involved a distinct pattern of serological reactivity to the EBV membrane antigens (MA), early antigens (EA), and the EBV nuclear antigen (EBNA). When it became generally accepted that the marked lymphocytosis , which is a hallmark of acute IM, was dominated by T cells, considerable effort was directed toward untangling the specificities that might be associated with restricting the proliferation of newly infected B cells. Early evidence was divided between support for both EBV non-specific and/or HLA non-restricted components. However, all results needed to be reassessed in light of the observation that T cells died by apoptosis within hours of separation from fresh blood from acute IM patients. The observation that EBV-infected cultures from immune (but not non-immune) individuals began to die (termed regression) about 10 days post-seeding, provided the first evidence of a specific memory response which was apparently capable of controlling the small pool of latently infected B cells which all immune individuals possess. In this early era, CD8(+) T cells were thought to be the effector population responsible for this phenomenon, but later studies suggested a role for CD4(+) cells. This historical review includes reference to key early observations in regard to both the specific humoral and cellular responses to EBV infection from the time of the discovery of the virus until 1990. As well, we have included personal recollections in regard to the events surrounding the discovery of the memory T cell response since we believe they add a human dimension to a chapter focussed on early history.
对爱泼斯坦-巴尔病毒(EBV)的早期研究源于该病毒被发现后不久所做的血清学观察。实际上,对多种EBV蛋白的体液反应的定义主导了早期文献,并为该病毒与传染性单核细胞增多症(IM)、伯基特淋巴瘤(BL)和鼻咽癌(NPC)的关联提供了关键证据。这些疾病关联中的每一种都涉及对EBV膜抗原(MA)、早期抗原(EA)和EBV核抗原(EBNA)的独特血清学反应模式。当急性IM的标志——明显的淋巴细胞增多被普遍认为由T细胞主导时,人们投入了大量精力来理清可能与限制新感染B细胞增殖相关的特异性。早期证据在支持EBV非特异性和/或HLA非限制性成分之间存在分歧。然而,鉴于从急性IM患者新鲜血液中分离数小时内T细胞就会因凋亡而死亡这一观察结果,所有结果都需要重新评估。来自免疫(而非非免疫)个体的EBV感染培养物在接种后约10天开始死亡(称为消退),这一观察结果提供了特异性记忆反应的首个证据,该反应显然能够控制所有免疫个体都拥有的少量潜伏感染B细胞。在这个早期阶段,CD8(+) T细胞被认为是负责这一现象的效应细胞群体,但后来的研究表明CD4(+)细胞也发挥了作用。这篇历史综述涵盖了从病毒发现到1990年期间关于EBV感染的特异性体液和细胞反应的关键早期观察。此外,我们还纳入了关于记忆性T细胞反应发现相关事件的个人回忆,因为我们认为它们为聚焦早期历史的篇章增添了人文色彩。